92 related articles for article (PubMed ID: 6307212)
1. Morphometric analysis of differentiation in human breast carcinoma. Tumor heterogeneity.
Sharkey FE
Arch Pathol Lab Med; 1983 Aug; 107(8):411-4. PubMed ID: 6307212
[TBL] [Abstract][Full Text] [Related]
2. Morphometric analysis of differentiation in human breast carcinoma. Tumor grading.
Sharkey FE; Pavlak RJ; Greiner AS
Arch Pathol Lab Med; 1983 Aug; 107(8):406-10. PubMed ID: 6307211
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
4. Mammary endocrine ductal carcinoma in situ: a case report.
Danikas D; Matthews WE; Averbach DJ
Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
[TBL] [Abstract][Full Text] [Related]
5. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ.
Bijker N; Peterse JL; Duchateau L; Robanus-Maandag EC; Bosch CA; Duval C; Pilotti S; van de Vijver MJ
Br J Cancer; 2001 Feb; 84(4):539-44. PubMed ID: 11207051
[TBL] [Abstract][Full Text] [Related]
6. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
8. E2F-1: a proliferative marker of breast neoplasia.
Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
[TBL] [Abstract][Full Text] [Related]
9. Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study.
Mouriquand J; Pasquier D
Acta Cytol; 1980; 24(2):153-9. PubMed ID: 6245554
[TBL] [Abstract][Full Text] [Related]
10. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
Crissman JD; Visscher DW; Kubus J
Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
[TBL] [Abstract][Full Text] [Related]
11. Morphologic identity of primary tumor and axillary metastases in breast carcinoma. A quantitative study.
Sharkey FE; Greiner AS
Arch Pathol Lab Med; 1985 Mar; 109(3):256-9. PubMed ID: 2983636
[TBL] [Abstract][Full Text] [Related]
12. [Frequency distribution, microscopic image analysis and grading of mammary carcinoma].
Guski H; Winzer KJ; Seidenfaden U; Hufnagl P; Wolf G
Zentralbl Pathol; 1991; 137(3):249-55. PubMed ID: 1718410
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
14. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
15. Morphometric analysis of endometrial adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma?
Zaino RJ; Laskaris A; Whitney C; Sharkey FE
Int J Gynecol Pathol; 1987; 6(1):12-9. PubMed ID: 3570628
[TBL] [Abstract][Full Text] [Related]
16. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
17. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
19. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
20. [Tumor properties of primary tumors and local recurrence of breast cancer].
Torsten U; Opri F; Moreno-Richter I; Weitzel HK
Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
